J9334 — Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
What the market charges
Across 1,064 negotiated rates, the middle 80% fall between $34 and $86, with a median of $41.
What Medicare pays
Medicare allowed an average of $32 for this code, across 189,616 services billed by 2 providers. At the median, the market charges 1.3 times what Medicare pays for this code.
Other codes
- J2777 — Injection, faricimab-svoa, 0.1 mg
- J0897 — Injection, denosumab, 1 mg
- J9271 — Injection, pembrolizumab, 1 mg
- J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- G0008 — Administration of influenza virus vaccine
- G0439 — Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9299 — Injection, nivolumab, 1 mg
- J1745 — Injection, infliximab, excludes biosimilar, 10 mg
- J2357 — Injection, omalizumab, 5 mg
Deploy this for your team
Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.
- Contact Mishe to learn how to deploy these resources for your team
- Guides to direct-pay healthcare
- Cash prices by procedure
- Find a provider by state
Take back healthcare.